Found "HTA": 318 results
The challenges in reimbursement decisions for innovative high-cost drugs: Thailand’s effort to expand drug access
The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide
Advancing the Institutionalization of Health Technology Assessment in Bhutan
Welcome to Bhutan, the land of the Thunder Dragon nested amidst the breathtaking grandeur of the Eastern Himalayas. Guided by the concept of the Gross National Happiness, Bhutan’s constitution mandates access to free basic public health services, for both modern and traditional medicine. Nonetheless
E^2U Research Unit under HITAP Develops Health Policy Options Based on ‘Environment-Economy’ Relationship
The world is rapidly changing. In mid-2023, NASA found that the average temperature in the Northern Hemisphere was the highest in 170 years, with ice melting 6-7 times faster compared to 25 years ago.
Antonio Guterres, the Secretary-General of the United Nations (UN), announced
Navigating Healthcare Innovations: Key Takeaways from the HIPER Symposium 2024
In a constantly evolving world of healthcare, staying updated and informed about new developments and innovations is essential. The Health Intervention and Technology Assessment Program (HITAP), a Health Technology Assessment (HTA) organisation in the Ministry of Public Health, Thailand, had the opp
Belt and Road: Cross-National Learning to Support Evidence-Informed Practice in Pediatric Healthcare
Beijing Children’s Hospital, Capital Medical University, National Centre for Children’s Health of China are committed to advancing skills in conducting comprehensive clinical evaluations of medicines. This commitment is evident through a variety of initiatives, including workshops, training, and aca
Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?
Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le
Implementing Health Tech for UHC: Real-World Lessons from PMAC 2025
The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com
PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health Coverage
PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health CoverageThis workshop will bring together journalists, bloggers and editors from around the world to share stories of reporting countries’ journey towards and efforts
Sir Michael David Rawlins gave a public lecture on Optimising health care in the UK National Health Service: Balancing quality and efficiency
On 28 January 2013, Sir Michael gave a public lecture on “Optimising health care in the UK National Health Service: Balancing quality and efficiency” as part of the PMAC conference. Due to the variable backgrounds of the attendees, this lecture aimed to introduce the term HTA and its roles in the Na
Vietnam Country Visit
( 11- 16 November 2013) Health Intervention and Technology Assessment Program (HITAP) researchers and the program leader, Dr. Yot Teerwattananon, made a scoping visit to Vietnam in November 2013. The purpose of the scoping visit was to evaluate the current status of Health Technology Assessment (HTA
10 / Page